Cargando…
Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies
Anderson–Fabry disease (AFD) is a rare disease with an incidenceof approximately 1:117,000 male births. Lysosomal accumulation of globotriaosylceramide (Gb3) is the element characterizing Fabry disease due to a hereditary deficiency α-galactosidase A (GLA) enzyme. The accumulation of Gb3 causes lyso...
Autores principales: | Tuttolomondo, Antonino, Simonetta, Irene, Riolo, Renata, Todaro, Federica, Di Chiara, Tiziana, Miceli, Salvatore, Pinto, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465525/ https://www.ncbi.nlm.nih.gov/pubmed/34576250 http://dx.doi.org/10.3390/ijms221810088 |
Ejemplares similares
-
Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020) -
Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease
por: Simonetta, Irene, et al.
Publicado: (2023) -
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease
por: Tuttolomondo, Antonino, et al.
Publicado: (2017) -
Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis
por: Puleo, Maria Grazia, et al.
Publicado: (2022) -
New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach
por: Simonetta, Irene, et al.
Publicado: (2022)